New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
09:09 EDTKOOLCesca Therapeutics, Cook Medical enter supply agreement for Phase 1b trial
Cesca Therapeutics announced today that they have entered a supply agreement with Cook Medical. Under the terms of the agreement, Cook Medical has been chosen as the supplier for select delivery device products for the Acute Myocardial Infarction Rapid Stem cell Therapy, or AMIRST, Phase 1b trial set to begin later this calendar year. The clinical trial is for targeted marketing approval in the United States, European Union Community and India.
News For KOOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
08:18 EDTKOOLCesca Therapeutics receives IEC/IRB approval to initiate AMI study
Subscribe for More Information
May 15, 2015
16:40 EDTKOOLCesca Therapeutics to delay filing Form 10-Q
The registrant is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, within the prescribed time period. As reported in the company’s Form 8-K dated May 12, the former independent registered public accounting firm resigned. The company needs more time to engage a successor independent registered public accounting firm and allow them time to review the management prepared Form 10-Q. No assurance can be given that the company will be able to file its quarterly report within the additional time prescribed by Rule 12b-25.
10:01 EDTKOOLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:10 EDTKOOLCesca Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Subscribe for More Information
May 13, 2015
06:03 EDTKOOLCesca Therapeutics submits U.S. IDE application for critical limb ischemia
Subscribe for More Information
May 12, 2015
18:03 EDTKOOLCesca Therapeutics begins search of new accounting firm
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use